- CRISPR-Cas9
- TALENs
- ZFNs
- Homing Endonucleases
- PASTE
- Prime Editing Systems
- Others
Genome editing market was valued at USD 5,648.3 Million in 2023 and is expected to grow at a CAGR of 12.8% from 2024-2030. The genome editing market is a fast-growing sector within the field of Biotechnology, offering revolutionary tools and techniques for editing the genetic makeup of the living organism to address various challenges in healthcare, agriculture, and other industries. According to the National Human Genome Research Institute, around 350 million people on earth have a rare disorder, which has been identified in fewer than 200,000 people. About 80% of these uncommon ailments are genetically based, and 95% don't even have one FDA-approved medication. This rising prevalence of rare genetic disorders, congenital disorders, and chronic diseases is driving the genome editing market.
Moreover, Advancements in genome editing techniques coupled with rising demand for personalized medicine and targeted therapies are accelerating the genome editing market further. However, ethical and regulatory concerns, off-target effects and safety concerns, delivery challenges, and high development and implementation costs are some of the factors that restrain the growth of the genome editing market. Furthermore, the genome editing market is witnessing several key trends including the development of novel genome editing tools, advancements in genome editing tool delivery systems, and the rise of therapeutic application. The growing interest and investment in genome editing research contribute to genome editing market growth and several companies are participating in launching new tools and techniques. In May 2023, Mission Bio introduced a new end-to-end product, Tapestri Genome Editing Solution, for the analysis of genome editing. In March 2021, Integrated DNA Technologies (IDT), a leading comprehensive genomics solutions provider, launched its rhAmpSeq CRISPR Analysis System, which offers an end-to-end solution for characterizing and quantifying the full array of on- and off-target genome editing events in CRISPR research projects.
Genome Editing Market Key Developments
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
The genome editing market is expected to rise with the increasing frequency of genetic disorders and chronic diseases, including albinism, Angelman syndrome, heart disease, Huntington’s disease, etc. Moreover, growing investment in genome editing research and improvements in innovative genome editing technologies like CRSPR-Cas9, TALENs, etc. aid in the advancement of the market as well as open up numerous opportunities for growth over the forecast years. In addition to the opportunities, the genome editing market confronts difficulties that need to be overcome, including genome editing in humans, off-target consequences, and the requirement for further long-term safety studies. Overall, the genome editing market is poised for significant growth and innovation. Ongoing research, collaborations, and advancements in genome editing technologies will continue to drive the market forward, enabling breakthroughs in healthcare, agriculture, and various other sectors.
Genome editing market was valued at USD 5,648.3 Million in 2023 and is expected to grow at a CAGR of 12.8% over 2024-2030.
Therapeutic applications, agricultural and livestock applications, research and drug discovery, development of gene therapies, expansion of targeted genetic modifications, and development of delivery systems are some of the potential opportunities for companies to enhance their revenue over the forecast years.
Expansion of CRISPR- Cas9 technology, development of novel genome editing tools, advancements in delivery techniques, and industrial application in the agriculture and biotechnology are some of the major trends in the genome editing market.
Lonza Group Ltd., Editas Medicine, Inc, Genscript Biotech Corporation, Eurofins Scientific, Perkinelmer, Inc., Merck Kgaa, Integrated Dna Technologies, Thermo Fisher Scientific, Inc, Crispr Therapeutics Ag, Danaher Corporation, Aglient Technologies, Inc., Pairwise, Mission Bio, Takara Bio, Inc., OriGene Technologies, Inc., Bio-Rad Laboratoies, Inc., Qiagen N.V. are some of the key players in the genome editing market.
1. Executive Summary |
2. Global Genome Editing Market Introduction |
2.1.Global Genome Editing Market - Taxonomy |
2.2.Global Genome Editing Market - Definitions |
2.2.1.Techniques |
2.2.2.Application |
2.2.3.End Users |
2.2.4.Region |
3. Global Genome Editing Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4. Global Genome Editing Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Genome Editing Market By Techniques, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. CRISPR-Cas9 |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. TALENs |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. ZFNs |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Homing Endonucleases |
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. PASTE |
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
5.6. Prime Editing Systems |
5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.6.3. Market Opportunity Analysis |
5.7. Others |
5.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.7.3. Market Opportunity Analysis |
6. Global Genome Editing Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Engineering Cell Lines and Organisms |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Synthetic Biology and Genome-Scale Engineering |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Therapeutic Genome Editing |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Diagnostics |
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Drug Discovery and Development |
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
6.6. Others |
6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.6.3. Market Opportunity Analysis |
7. Global Genome Editing Market By End Users, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Biotechnology and Pharmaceutical Companies |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Academic and Research Organizations |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Contract Research Organisations |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Others |
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
8. Global Genome Editing Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9. North America Genome Editing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Techniques Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.CRISPR-Cas9 |
9.1.2.TALENs |
9.1.3.ZFNs |
9.1.4.Homing Endonucleases |
9.1.5.PASTE |
9.1.6.Prime Editing Systems |
9.1.7.Others |
9.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Engineering Cell Lines and Organisms |
9.2.2.Synthetic Biology and Genome-Scale Engineering |
9.2.3.Therapeutic Genome Editing |
9.2.4.Diagnostics |
9.2.5.Drug Discovery and Development |
9.2.6.Others |
9.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Biotechnology and Pharmaceutical Companies |
9.3.2.Academic and Research Organizations |
9.3.3.Contract Research Organisations |
9.3.4.Others |
9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10. Europe Genome Editing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Techniques Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.CRISPR-Cas9 |
10.1.2.TALENs |
10.1.3.ZFNs |
10.1.4.Homing Endonucleases |
10.1.5.PASTE |
10.1.6.Prime Editing Systems |
10.1.7.Others |
10.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Engineering Cell Lines and Organisms |
10.2.2.Synthetic Biology and Genome-Scale Engineering |
10.2.3.Therapeutic Genome Editing |
10.2.4.Diagnostics |
10.2.5.Drug Discovery and Development |
10.2.6.Others |
10.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Biotechnology and Pharmaceutical Companies |
10.3.2.Academic and Research Organizations |
10.3.3.Contract Research Organisations |
10.3.4.Others |
10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
10.4.6.Rest of EU |
11. Asia Pacific (APAC) Genome Editing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Techniques Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.CRISPR-Cas9 |
11.1.2.TALENs |
11.1.3.ZFNs |
11.1.4.Homing Endonucleases |
11.1.5.PASTE |
11.1.6.Prime Editing Systems |
11.1.7.Others |
11.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Engineering Cell Lines and Organisms |
11.2.2.Synthetic Biology and Genome-Scale Engineering |
11.2.3.Therapeutic Genome Editing |
11.2.4.Diagnostics |
11.2.5.Drug Discovery and Development |
11.2.6.Others |
11.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Biotechnology and Pharmaceutical Companies |
11.3.2.Academic and Research Organizations |
11.3.3.Contract Research Organisations |
11.3.4.Others |
11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12. Middle East and Africa (MEA) Genome Editing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Techniques Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.CRISPR-Cas9 |
12.1.2.TALENs |
12.1.3.ZFNs |
12.1.4.Homing Endonucleases |
12.1.5.PASTE |
12.1.6.Prime Editing Systems |
12.1.7.Others |
12.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Engineering Cell Lines and Organisms |
12.2.2.Synthetic Biology and Genome-Scale Engineering |
12.2.3.Therapeutic Genome Editing |
12.2.4.Diagnostics |
12.2.5.Drug Discovery and Development |
12.2.6.Others |
12.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Biotechnology and Pharmaceutical Companies |
12.3.2.Academic and Research Organizations |
12.3.3.Contract Research Organisations |
12.3.4.Others |
12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13. Latin America Genome Editing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Techniques Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.CRISPR-Cas9 |
13.1.2.TALENs |
13.1.3.ZFNs |
13.1.4.Homing Endonucleases |
13.1.5.PASTE |
13.1.6.Prime Editing Systems |
13.1.7.Others |
13.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Engineering Cell Lines and Organisms |
13.2.2.Synthetic Biology and Genome-Scale Engineering |
13.2.3.Therapeutic Genome Editing |
13.2.4.Diagnostics |
13.2.5.Drug Discovery and Development |
13.2.6.Others |
13.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Biotechnology and Pharmaceutical Companies |
13.3.2.Academic and Research Organizations |
13.3.3.Contract Research Organisations |
13.3.4.Others |
13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Lonza Group Ltd. |
14.2.2.Editas Medicine, Inc |
14.2.3.Genscript Biotech Corporation |
14.2.4.Eurofins Scientific |
14.2.5.Perkinelmer, Inc. |
14.2.6.Merck Kgaa |
14.2.7.Integrated Dna Technologies |
14.2.8.Thermo Fisher Scientific, Inc |
14.2.9.Crispr Therapeutics Ag |
14.2.10.Danaher Corporation |
14.2.11.Aglient Technologies, Inc. |
14.2.12.Pairwise |
14.2.13.Mission Bio |
14.2.14.Takara Bio, Inc. |
14.2.15.OriGene Technologies, Inc. |
14.2.16.Bio-Rad Laboratoies, Inc. |
14.2.17.Qiagen N.V. |
15. Research Methodology |
16. Appendix and Abbreviations |